FOLH1 and neoplasm: At 24 h post-injection (p.i.), conjugates of antibody fragments were cleared from the PSMA-negative tumor (PSMA−) and inner organs and a fluorescence signal was restricted to the PSMA-positive tumor only (PSMA+).